Wife convicted of poisoning husband with nicotine in South Korea

Aug.29.2022
Wife convicted of poisoning husband with nicotine in South Korea
A Korean man died from nicotine poisoning, and his wife was suspected of intentionally feeding him the substance.

On a morning in May 2021, a Korean man named A unexpectedly passed away in his home at approximately 7 a.m. After conducting an autopsy, it was determined that the cause of death was nicotine poisoning. As a result, A's wife, B, was named as a suspect in a criminal investigation by the authorities.


Miancha, baizhou, and nicotine solution.


According to reports, A had left work early the day before his death because he was feeling unwell. In a conversation with his wife, B, she informed him that the cause of his illness might have been the expired honey added to his breakfast tea. A was taken to the emergency room shortly after returning home and underwent simple tests and rest before being discharged. He then passed away the following day.


According to the prosecution and the police, it has been suggested that the amount of nicotine found in A's body and their dietary intake indicate that B fed A liquid nicotine three times. It has been reported that B gave A tea containing nicotine in the morning, rice soup containing nicotine when he returned home, and water mixed with liquid nicotine after A returned from the emergency room.


The wife stated that there was no reason to kill her husband.


B claims that "this is a medical accident, she did not kill her husband, and there was no reason for her to do so." The police presented evidence that B had purchased nicotine liquid from a nearby vape shop a few days before the incident. B initially stated that she had bought it for her husband who smoked. However, after investigating the people around A and her credit card usage, the police discovered that A quit smoking eight years ago. B then changed her story and claimed that she had bought the liquid for herself to smoke.


Furthermore, B claims that her husband, A, attempted suicide several months ago and that suicide-related search terms were found on his phone. During this same time, B was involved in a long-term extramarital affair with another man while also accumulating debts exceeding 100 million Korean won.


Most people in the area reported that A's husband also became aware of this fact and, as a result, the couple had a serious argument. The husband also has over 100 million Korean won in life insurance.


According to the judiciary department, the motive for B's murder, which included adultery and debt, was deemed sufficient.


The judiciary department believes that B has a criminal motive.


Firstly, B, the wife, revealed that she had conflicts with her husband in order to maintain a long-term relationship with her lover. If her husband were to die, it would solve her financial difficulties. Furthermore, information left behind by A indicated that he worked hard to support himself and his beloved son, in addition to his profession. There is no reason to believe that he would have made such an extreme choice, given the absence of a suicide note.


In the end, B was sentenced to 30 years in prison and is currently serving the sentence.


Disclaimer: 1. This article is compiled from third-party sources and is only intended for industry communication and learning purposes. 2. The views expressed in this article do not represent those of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The compilation of this article is only intended for industry communication and research purposes. 3. Due to the limited level of compilation, the compiled article may not express exactly the same meaning as the original. Please refer to the original article for accuracy. 4. 2FIRSTS maintains complete consistency with the Chinese government on any statement or position pertaining to domestic, Hong Kong, Macao, and Taiwan, as well as foreign issues. 5. The copyright for the compiled information belongs to the original media and the authors. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
At InterTabac 2026 in Dortmund, PMI is presenting multiple brands and products along “The PMI Boulevard,” including IQOS, ZYN, VEEV and Marlboro. On-site images captured by 2Firsts show dedicated spaces including the IQOS Boutique, ZYN Café, PMI Gallery and Marlboro Office
Market
Sep.16 by 2Firsts Perspectives
Product | Philip Morris Japan Teams Up With Renowned French Audio Brand DEVIALET for Limited-Edition IQOS Priced 60% Above Standard Model
Product | Philip Morris Japan Teams Up With Renowned French Audio Brand DEVIALET for Limited-Edition IQOS Priced 60% Above Standard Model
Philip Morris Japan (PMJ) launched the limited-edition IQOS ILUMA i PRIME Soundsorial Model in collaboration with French audio brand DEVIALET on October 1, 2026. Featuring sound-wave patterns, a silver-and-black finish and a gradient holder, the heated tobacco device is priced at JPY 15,980, including tax, and is available at four IQOS stores in Japan. According to Japanese media citing a PMJ representative, about 1,900 units were allocated to the Japanese retail market. A separate Soundsorial Collection, combining the device with DEVIALET Gemini II earbuds, includes 440 sets allocated to Japan for a membership prize draw.
product
Oct.23
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Raja Krishnamoorthi on Oct. 6 questioned the FDA over its plan to reassess and potentially replace the 2021 PMTA regulatory framework, asking the agency to identify provisions it may change or eliminate, state whether current scientific evidentiary standards will be maintained, and disclose communications with Altria, Reynolds and other parties challenging the rule. Krishnamoorthi led a congressional investigation into JUUL and youth vaping in 2019 and has since remained active on e-cigarette regulation and enforcement.
Regulations
Oct.08
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
A study by CDC Foundation researchers found no sustained decline in e-cigarette sales across Alabama, Oklahoma and Louisiana, the first three U.S. states to implement e-cigarette directory laws. Louisiana initially saw a significant sales decline, followed by a rebound and a persistent reduction in product availability. Sales also shifted from nontobacco-flavored disposables toward prefilled cartridges, with Vuse Alto driving much of the increase in menthol cartridges. By April 2025, unlisted products still accounted for more than half of e-cigarette nicotine sales in all three states.
Sep.18
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Alimentation Couche-Tard said U.S. same-store sales in its “other nicotine products” category grew at a double-digit rate in the first quarter of fiscal 2027, led by nicotine pouches, while overall U.S. same-store merchandise revenues increased 1.7%. The company also said its Canadian nicotine business continued to face regulatory pressure and illicit-market headwinds. The U.S. performance coincides with Couche-Tard's participation in efforts to reopen Canadian convenience-store access to authorized nicotine pouches, though the company has not established a direct causal link between the two.
Sep.14